Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 30, Number 11—November 2024
Dispatch

Fatal Oropouche Virus Infections in Nonendemic Region, Brazil, 2024

Antonio Carlos Bandeira, Felicidade Mota Pereira, Arabela Leal, Sara P.O. Santos, Ana Claudia Barbosa, Marcia Sao Pedro Leal Souza, Daniele Ribeiro de Souza, Natalia Guimaraes, Vagner Fonseca, Marta Giovanetti, Luiz Carlos Junior Alcantara, André Alvarez A. Lessa, Ramon Costa Saavedra, Luiz Marcelo R. Tomé, Felipe Campos M. Iani, Rivia Mary Barros, Sandra Maria O. Purificação, Jaciara Prado de Jesus, Ricardo Rosário Fonseca, and Marcio Luis Valença AraújoComments to Author 
Author affiliations: Laboratório Central de Saúde Pública da Bahia, Salvador, Brazil (A.C. Bandeira, F. Mota Pereira, A. Leal, S.P.O. Santos); Diretoria de Vigilância Epidemiológica do Estado da Bahia, Salvador (A.C. Barbosa, M.S.P.L. Souza, D.R. de Souza, A.A.A. Lessa, R.C. Saavedra, S.M. de Oliveira da Purificação, J.P. de Jesus, M.L.V. Araújo); Fundação Ezequiel Dias, Belo Horizonte, Brazil (N. Guimaraes, F.C.M. Iani); University of the State of Bahia, Salvador (V. Fonseca); Universita Campus Bio-Medico di Roma, Rome, Italy (M. Giovanetti); Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil (M. Giovanetti); Instituto Rene Rachou, Fundação Oswaldo Cruz, Minas Gerais, Brazil (L.C.J. Alcantara, L.M.R. Tomé); Superintendência de Vigilância em Saúde, Salvador (R.M. Barros); Santa Casa de Misericórdia de Valença Hospital, Valença, Brazil (R.R. Fonseca); Instituto Federal de Educação, Salvador (M.L.V. Araújo)

Main Article

Table 2

Laboratory test results for patient 2 in a case of fatal Oropouche virus infection in nonendemic region, Brazil, 2024*

Variable Time after admission
At admission 10 hours
Hematocrit, % 38.7 43.7
Hemoglobin, % 13.5 14.0
Mean corpuscular volume, fL (reference <80 fL) 86 82
Mean corpuscular hemoglobin, pg (reference 27–31 pg) 30 26
Leukocytes, cells/mm3 9,500 19,400
Neutrophils, % 59 58
Band forms, % 0 0
Metamyelocytes, % 0 0
Lymphocytes, % 34 36
Platelets, cells/mm3 147,000 91,000
Prothrombin time, sec ND >120
Partial thromboplastin time, sec ND >120
Bleeding time, min ND 5
Clotting time, min ND >30
TB/DB, mg/dL ND 2.71/1.54
Creatinine, mg/dL ND 3.6
NS1 Nonreactive ND

*Patient was transferred to a second hospital after initial admission. ND, not done; NS1, rapid immunochromatographic test for dengue virus; TB/DB, total/direct bilirubin.

Main Article

Page created: September 10, 2024
Page updated: September 13, 2024
Page reviewed: September 13, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external